Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology. 2013;58:2142–52.
Roos M, Brodbeck J, Sarkozy A, Chierchia GB, De Asmundis C, Brugada P. A critical analysis of the scientific evidence behind international guidelines related to cardiac arrhythmias. Circ Arrhythm Electrophysiol. 2011;4:202–10.
Neuman MD, Goldstein JN, Cirullo MA, Schwartz JS. Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations. JAMA. 2014;311:2092–100.
Wright JD, Pawar N, Gonzalez JSR, Lewin SN, Burke WM, Simpson LL, et al. Scientific evidence underlying the American College of Obstetricians and Gynecologists’ practice bulletins. Obstet Gynecol. 2011;118:505–12.
Feuerstein JD, Akbari M, Gifford AE, Hurley CM, Leffler DA, Sheth SG, et al. Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines. Mayo Clin Proc. 2014;89:16–24.
Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301:831–41.
Han H, Chao H, Guerra A, Sosa A, Christopoulos G, Christakopoulos GE, et al. Evolution of the American College of Cardiology/American Heart Association clinical guidelines. J Am Coll Cardiol. 2015;65:2726–34.
Califf RM. The cycle of quality as a model for improving health outcomes in the treatment of hypertension. European Heart Journal Supplements. 2007;9:B8–12.
Crowley WF Jr, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, et al. Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. JAMA. 2004;291:1120–6.
Alper J, Grossmann C. Integrating research and practice: health system leaders working toward high-value care: workshop summary. Washington, D.C: The National Academies Press; 2015.
Committee on the Learning Health Care System in America, Institute of Medicine. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America [Internet]. Smith M, Saunders R, Stuckhardt L, McGinnis JM, editors. Washington (DC): National Academies Press (US); 2013 [cited 2015 Jan 28] Available from: http://www.ncbi.nlm.nih.gov/books/NBK207225/
Ford I, Norrie J. Pragmatic trials. Drazen JM, Harrington DP, McMurray JJV, Ware JH, Woodcock J, editors. N Engl J Med 2016;375:454–463.
Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350:h2147.
Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62:464–75.
O’Rourke PP, Carrithers J, Patrick-Lake B, Rice TW, Corsmo J, Hart R, et al. Harmonization and streamlining of research oversight for pragmatic clinical trials. Clin Trials. 2015;12:449–56.
RFA-RM-13-012. NIH Health Care Systems Research Collaboratory - Demonstration Projects for Pragmatic Clinical Trials Focusing on Multiple Chronic Conditions (UH2/UH3). 2013 [cited 2015 Feb 10]; Available from: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-012.html
Sugarman J. Ethics of research in usual care settings: data on point. AJOB Empirical Bioethics. 2016;7:71–5.
Weinfurt KP, Bollinger JM, Brelsford KM, Crayton TJ, Topazian RJ, Kass NE, et al. Patients’ views concerning research on medical practices: implications for consent. AJOB Empirical Bioethics. 2016;7:76–91.
Califf RM, Sugarman J. Exploring the ethical and regulatory issues in pragmatic clinical trials. Clinical Trials. 2015;12:436–41.
Smalley JB, Merritt MW, Al-Khatib SM, McCall D, Staman KL, Stepnowsky C. Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials. Clinical Trials. 2015;12:476–84.
Finkelstein JA, Brickman AL, Capron A, Ford DE, Gombosev A, Greene SM, et al. Oversight on the borderline: quality improvement and pragmatic research. Clinical Trials. 2015;12:457–66.
McGraw D, Greene SM, Miner CS, Staman KL, Welch MJ, Rubel A. Privacy and confidentiality in pragmatic clinical trials. Clinical Trials. 2015;12:520–9.
McKinney RE, Beskow LM, Ford DE, Lantos JD, McCall J, Patrick-Lake B, et al. Use of altered informed consent in pragmatic clinical research. Clin Trials. 2015;12:494–502.
Ali J, Andrews JE, Somkin CP, Rabinovich CE. Harms, benefits, and the nature of interventions in pragmatic clinical trials. Clinical Trials. 2015;12:467–75.
Anderson ML, Griffin J, Goldkind SF, Zeitler EP, Wing L, Al-Khatib SM, et al. The Food and Drug Administration and pragmatic clinical trials of marketed medical products. Clinical Trials. 2015;12:511–9.
Ellenberg SS, Culbertson R, Gillen DL, Goodman S, Schrandt S, Zirkle M. Data monitoring committees for pragmatic clinical trials. Clinical Trials. 2015;12:530–6.
Lantos JD, Wendler D, Septimus E, Wahba S, Madigan R, Bliss G. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials. Clinical Trials. 2015;12:485–93.
Welch MJ, Lally R, Miller JE, Pittman S, Brodsky L, Caplan AL, et al. The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials. Clinical Trials. 2015;12:503–10.
Whicher DM, Miller JE, Dunham KM, Califf RM, Joffe S. Gatekeepers for pragmatic clinical trials. Clinical Trials. 2015;12:442–8.
Locklear T, DeBar LL, Willig J, Rundell S, Blackhall L, Zatzick D, et al. Case Studies from the Clinic: Initiating and Implementing Patient-Reported Outcome Measures. eGEMs (Generating Evidence & Methods to improve patient outcomes). 2017;5:1.
Richesson RL, Hammond WE, Nahm M, Wixted D, Simon GE, Robinson JG, et al. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH health care systems Collaboratory. J Am Med Inform Assoc. 2013;20(e2):e226–31.
Rachel L. Richesson, Beverly B. Green, Reesa Laws, Jon puro, Michael G. Kahn, Alan Bauck, et al. Pragmatic (trial) informatics: a perspective from the NIH health care systems research Collaboratory. J Am Med Inform Assoc. 2017;24(5):996–1001.
Zozus MN, Richesson RL, Walden A, Tenenbaum JD, Hammond WE. Research reproducibility in longitudinal multi-center studies using data from electronic health records. AMIA Jt Summits Transl Sci Proc. 2016;2016:279–85.
Johnson KE, Tachibana C, Coronado GD, Dember LM, Glasgow RE, Huang SS, et al. A guide to research partnerships for pragmatic clinical trials. BMJ. 2014;349:g6826.
Larson EB, Tachibana C, Thompson E, Coronado GD, DeBar L, Dember LM, et al. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems. Healthcare. 2015;4:138–44.
Larson EB, Johnson K. Making new care models a reality requires closer collaboration between researchers and execs. Modern Healthcare [Internet]. [cited 2015 Aug 25]; Available from: http://www.modernhealthcare.com/article/20150822/MAGAZINE/308229977/closer-collaboration-among-researchers-execs-needed
Moloney RM, Tambor ES, Tunis SR. Patient and clinician support for the learning healthcare system: recommendations for enhancing value. J Comp Eff Res. 2016;5:123–8.
Li F, Lokhnygina Y, Murray DM, Heagerty PJ, DeLong ER. An evaluation of constrained randomization for the design and analysis of group-randomized trials. Stat Med. 2016;35:1565–79.
Cook AJ, Delong E, Murray DM, Vollmer WM, Heagerty PJ. Statistical lessons learned for designing cluster randomized pragmatic clinical trials from the NIH health care systems Collaboratory biostatistics and design Core. Clinical Trials. 2016;13:504–12.
Langley GJ, editor. The improvement guide: a practical approach to enhancing organizational performance. 2nd ed. San Francisco: Jossey-Bass; 2009.
NIH Collaboratory Healthcare Systems Interactions Core. Lessons Learned from the NIH Health Care Systems Research Collaboratory Demonstration Projects [Internet]. 2016 [cited 2016 Sep 1] Available from: https://www.nihcollaboratory.org/Products/Lessons%20Learned%20from%20the%20NIH%20Collaboratory%20Demonstration%20Projects_V1.0.pdf
NIH Collaboratory, Health Care Systems Interactions Core. Considerations for Training Front-Line Staff and Clinicians on Pragmatic Clinical Trial Procedures [Internet]. 2105 [cited 2017 Mar 21] Available from: https://www.nihcollaboratory.org/Products/PCT%20Front-Line%20Training%20Guidance.pdf
Topazian R, Bollinger J, Weinfurt KP, Dvoskin R, Mathews D, Brelsford K, et al. Physicians’ perspectives regarding pragmatic clinical trials. J Comp Eff Res. 2016;5:499–506.
Department of Health and Human Services. Standards for Privacy of Individually Identifiable Health Information [Internet]. 45 CFR Parts 160 and 164; 2002 [cited 2013 Dec 18] Available from: https://www.hhs.gov/hipaa/for-professionals/privacy/index.html
Code of Federal Regulations | HHS.gov [Internet]. [cited 2014 Oct 8] Available from: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html
Sugarman J, Califf RM. Ethics and regulatory complexities for pragmatic clinical trials. JAMA. 2014;311:2381–2.
Simon GE. Suicide Prevention Outreach Trial [Internet]. NIH Collaboratory Steering Committee Meeting. 2015 [cited 2015 Oct 20] Available from: https://www.nihcollaboratory.org/Documents/Suicide%20Prevention_Simon_04-21-15.pdf
NIH Collaboratory. An Interview with Lynn DeBar [Internet]. 2015 [cited 2015 Oct 20]. Available from: https://www.nihcollaboratory.org/Pages/DeBar%20PPACT%20Interview%207-27-15.pdf
Neff KM, Nawarskas JJ. Hydrochlorothiazide versus chlorthalidone in the management of hypertension. Cardiol Rev. 2010;18:51–6.